The currently assigned organic peroxides specifically listed in packing instruction IBC520 may be carried in IBCs in accordance with this packing instruction. IBCs shall conform to the requirements of Chapter 6.5 and shall meet its test requirements for packing group II.

Other organic peroxides and self-reactive substances of type F may be carried in IBCs under conditions established by the competent authority of the country of origin when, on the basis of the appropriate tests, that competent authority is satisfied that such carriage may be safely conducted. The tests undertaken shall include those necessary:

(a) To prove that the organic peroxide (or self-reactive substance) complies with the principles for classification given in 20.4.3 (f) [resp. 20.4.2 (f)] of the Manual of Tests and Criteria, exit box F of Figure 20.1 (b) of the Manual;

(b) To prove the compatibility of all materials normally in contact with the substance during carriage;

(c) To determine, when applicable, the control and emergency temperatures associated with the carriage of the product in the IBC concerned as derived from the SADT;

(d) To design, when applicable, pressure and emergency relief devices; and

(e) To determine if any special provisions are necessary for safe carriage of the substance.

If the country of origin is not a Contracting Party to ADR, the classification and transport conditions shall be recognized by the competent authority of the first country Contracting Party to ADR reached by the consignment.

Emergencies to be taken into account are self-accelerating decomposition and fire engulfment. To prevent explosive rupture of metal or composite IBCs with a complete metal casing, the emergency- relief devices shall be designed to vent all the decomposition products and vapours evolved during self-accelerating decomposition or during a period of not less than one hour of complete fire engulfment calculated by the equations given in 4.2.1.13.8.

Consignors of infectious substances shall ensure that packages are prepared in such a manner that they arrive at their destination in good condition and present no hazard to persons or animals during carriage.

The definitions in 1.2.1 and the general packing provisions of 4.1.1.1 to 4.1.1.17, except 4.1.1.10 to 4.1.1.12 and 4.1.1.15 apply to infectious substances packages. However, liquids shall only be filled into packagings which have an appropriate resistance to the internal pressure that may develop under normal conditions of carriage.

An itemized list of contents shall be enclosed between the secondary packaging and the outer packaging. When the infectious substances to be carried are unknown, but suspected of meeting the criteria for inclusion in Category A, the words "suspected Category A infectious substance" shall be shown, in parenthesis, following the proper shipping name on the document inside the outer packaging.

Before an empty packaging is returned to the consignor, or sent elsewhere, it shall be disinfected or sterilized to nullify any hazard and any label or mark indicating that it had contained an infectious substance shall be removed or obliterated.

Provided an equivalent level of performance is maintained, the following variations in the primary receptacles placed within a secondary packaging are allowed without the need for further testing of the completed packaging:
(a) Primary receptacles of equivalent or smaller size as compared to the tested primary receptacles may be used provided:
(i) the primary receptacles are of similar design to the primary receptacle tested (e.g. shape: round, rectangular, etc.);
(ii) the material of construction of the primary receptacles (e.g. glass, plastics, metal) offers resistance to impact and stacking forces equivalent to or better than that of the primary receptacles originally tested;
(iii) the primary receptacles have the same or smaller openings and the closure is of equivalent design (e.g. screw cap, friction lid, etc.);
(iv) sufficient additional cushioning material is used to take up empty spaces and to prevent significant movement of the primary receptacles; and
(v) primary receptacles are oriented within the secondary packagings in the same manner as in the tested package;
(b) A lesser number of the tested primary receptacles, or of the alternative types of primary receptacles identified in (a) above, may be used provided sufficient cushioning is added to fill the void space(s) and to prevent significant movement of the primary receptacles.

Paragraphs 4.1.8.1 to 4.1.8.5 only apply to infectious substances of Category A (UN Nos. 2814 and 2900). They do not apply to UN No. 3373 BIOLOGICAL SUBSTANCE, CATEGORY B (see packing instruction P650 of 4.1.4.1), nor to UN No. 3291 CLINICAL WASTE, UNSPECIFIED, N.O.S. or (BIO) MEDICAL WASTE, N.O.S. or REGULATED MEDICAL WASTE, N.O.S.

For the carriage of animal material, packagings or IBCs not specifically authorized in the applicable packing instruction shall not be used for the carriage of a substance or article unless specifically approved by the competent authority of the country of origin2 and provided:
(a) The alternative packaging complies with the general requirements of this Part;
(b) When the packing instruction indicated in Column (8) of Table A of Chapter 3.2 so specifies, the alternative packaging meets the requirements of Part 6;
(c) The competent authority of the country of origin2 determines that the alternative packaging provides at least the same level of safety as if the substance were packed in accordance with a method specified in the particular packing instruction indicated in Column (8) of Table A of Chapter 3.2; and
(d) A copy of the competent authority approval accompanies each consignment or the transport document includes an indication that alternative packaging was approved by the competent authority.

‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑                 
2    If the country of origin is not a Contracting Party to ADR, the competent authority of the first Contracting Party
to the ADR reached by the consignment

Radioactive material, packagings and packages shall meet the requirements of Chapter 6.4. The quantity of radioactive material in a package shall not exceed the limits specified in 2.2.7.2.2, 2.2.7.2.4.1, 2.2.7.2.4.4, 2.2.7.2.4.5, 2.2.7.2.4.6, special provision 336 of Chapter 3.3 and 4.1.9.3.

The types of packages for radioactive materials covered by ADR, are:

(a) Excepted package (see 1.7.1.5);

(b) Industrial package Type 1 (Type IP-1 package);

(c) Industrial package Type 2 (Type IP-2 package);

(d) Industrial package Type 3 (Type IP-3 package);

(e) Type A package;

(f) Type B(U) package;

(g) Type B(M) package;

(h) Type C package.

Packages containing fissile material or uranium hexafluoride are subject to additional requirements.

The non-fixed contamination on the external surfaces of any package shall be kept as low as practicable and, under routine conditions of transport, shall not exceed the following limits:

(a) 4 Bq/cm2 for beta and gamma emitters and low toxicity alpha emitters; and

(b) 0.4 Bq/cm2 for all other alpha emitters.

These limits are applicable when averaged over any area of 300 cm2 of any part of the surface